Latest Breaking News On - Project integrum - Page 1 : comparemela.com

Biocytogen Launches RenBiologics, A Sub-Brand Focused on Out-Licensing Fully Human Antibodies For Therapeutic Development

Biocytogen Launches RenBiologics, A Sub-Brand Focused on Out-Licensing Fully Human Antibodies For Therapeutic Development
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesSan franciscoJunshi biosciencesYuelei shenHansoh pharmaHaimen jiangsuChipscreen newway biosciencesDevelopment businessMerck kgaMerck kgaaBiocytogen pharmaceuticals beijing co ltdEco development businessProject integrumRona therapeuticsFully humanPlatform licensing business

Biocytogen Launches RenBiologics A SubBrand Focused on OutLicensing Fully Human Antibodies For Therapeutic Development

Biocytogen Pharmaceuticals Beijing Co. Ltd. Biocytogen HKEX 02315 today announced the launch of a new subbrand RenBiologics to represent the companys antibody discovery business division.

San franciscoUnited statesHansoh pharmaJunshi biosciencesHaimen jiangsuYuelei shenChipscreen newway biosciencesMerck kgaDevelopment businessBiocytogen pharmaceuticals beijing co ltdMerck kgaaEco development businessProject integrumRona therapeuticsFully humanPlatform licensing business

Biocytogen Launches RenBiologics, A Sub-Brand Focused on Out-Licensing Fully Human Antibodies For Therapeutic Development

BEIJING Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”, HKEX: 02315) today announced the launch of a new sub-brand, RenBiologics

United statesNew yorkSan franciscoChipscreen newway biosciencesBarbara shecterJunshi biosciencesGabriel friedmanHansoh pharmaJoe oconnorHaimen jiangsuYuelei shenJoe oliverNational postBiocytogen pharmaceuticals beijing co ltdMerck kgaCanada revenue agency

Biocytogen Enters into Antibody Agreement with Ona Therapeutics to Develop AntibodyDrug Conjugates Targeting Solid Tumors

Biocytogen Pharmaceuticals Beijing Co. Ltd. Biocytogen HKEX 02315 a global biotech company focusing on the discovery and development of novel antibody therapeutics today announces an antibody evaluation option and license agreement with Ona Therapeutics Ona a Spanish biotech company specialized in unravelling novel biology to design biopharmaceuticals attacking advanced cancer.

San franciscoUnited statesComunidad autonoma de catalunaHaimen jiangsuValerie vanhoorenYuelei shenInstitute for researchBiocytogen pharmaceuticals beijing co ltdRona therapeuticsProject integrumBarcelona science parkFierce biotechMedia contactBiocytogen pharmaceuticals novel antibody therapeutics ona biopharmaceuticals antibodydrug conjugate dr yuelei shen valerie vanhooren renmice multinational pharmaceutical companies

Biocytogen Announces 16 Poster Presentations and Booth Exhibition at SITC 2023

Biocytogen Announces 16 Poster Presentations and Booth Exhibition at SITC 2023
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

San diegoUnited statesSan franciscoIntegrum renmiceRenmabtm renliteHaimen jiangsuBiocytogen pharmaceuticals beijing co ltdProduct serviceSociety for immunotherapy of cancerBooth exhibitionShelf mouse modelsTarget humanizedProject integrum